Blog Band - Page 262 of 299

06

Biosimilars are developed to be highly similar versions of approved biologics in terms of safety, purity, and potency Biosimilars are expected to be a cost-effective alternative to the high-priced branded…

05

Jan 2022

VIEWPOINTS

PharmaShots Interview: Guardant Health’s Justin Odegaard Shares Insights on the Data of Guardant360 Liquid Biopsy Test Published in Nature Medicine

In an interview with PharmaShots, Justin Odegaard, Vice President of Clinical Development and a Laboratory Director at Guardant Health & Yoshiaki Nakamura, Staff Physician in the Department of Gastroenterology and Gastrointestinal…

04

Jan 2022

VIEWPOINTS

PharmaShots Interview: Janssen’s Alyssa Johnsen Shares Insights on the New Clinical data of Tremfya (guselkumab) Presented at ACR 2021 and Published in Arthritis & Rheumatology

In an interview with PharmaShots, Alyssa Johnsen, MD, Ph.D., Vice President, Rheumatology and Maternal-Fetal Health Disease Area Leader at Janssen Research & Development shares her views on the P-III DISCOVER-1 & 2 Studies of Tremfya (guselkumab) for…

03

Jan 2022

VIEWPOINTS

PharmaShots Interview: Alto Neuroscience’s Dr. Amit Etkin Shares Insights on the Future of Psychiatric Medicines

In an interview with PharmaShots, Dr. Amit Etkin, CEO and Founder of Alto Neuroscience shared his views on its clinical stage pipeline in the emerging hot precision psychiatry space. He also put his views on…

30

Dec 2021

VIEWPOINTS

PharmaShots Interview: Clario’s Joe Eazor Shares Insight on the Clinical Trial Innovation and Evidence

In an interview with PharmaShots, Joe Eazor, CEO at Clario share his views on the ERT’s merger with Bioclinica to become Clario for clinical trial innovation and evidence ERT & Bioclinica merged to become Clario, following its Apr…

29

Dec 2021

VIEWPOINTS

PharmaShots Interview: Synchrony’s Shannon Burke Shares Insight on Healthcare Consumerism

In an interview with PharmaShots, Shannon Burke, Synchrony Senior Vice President, and General Manager, Health Systems, share her views on healthcare financing & empowers the patients to pay for their healthcare Synchrony’s CareCredit card…

28

Dec 2021

VIEWPOINTS

PharmaShots Interview: IMV’s Andrew Hall Shares Insight on DPX Technology for Bladder and Ovarian Cancer

In an interview with PharmaShots, Andrew Hall, CEO at IMV share his views on the data of DPX delivery platform in the bladder and ovarian cancer, presented in two e-posters at the AACR-NCI-EORTC virtual conference Shots:…

27

Dec 2021

EXCLUSIVE

Exclusive Interview with PharmaShots: Jeremiah Robison of Cionic Share Insight on the New Data of Neural Sleeve for Neurological & other Disorders

In an interview with PharmaShots, Jeremiah Robison, Founder, and CEO at Cionic shared his views on the data of the Neural Sleeve gait study for patients with cerebral palsy, MS, stroke, and other neurological disorders…

23

Dec 2021

TOP 20

TOP 20 Animal Health Companies of 2020 by Total Revenue

Humans depends on livestock for survival and Animal Health has always been an issue to look for since it directly reflects the betterment of human life For a country’s economy…

22

Dec 2021

VIEWPOINTS

PharmaShots Interview: Trialbee’s Matt Walz Shares Insight on Trialbee Honey Platform

In an interview with PharmaShots, Matt Walz, CEO at Trialbee share his views on the launch of the Trialbee Honey platform to empower patient recruitment Shots: Trialbee launched Trialbee Honey that allows to track, measure, and analyze all…

Insights+ Key Biosimilars Events of December 2021

PharmaShots Interview: Guardant Health’s Justin Odegaard Shares Insights on the Data of Guardant360 Liquid Biopsy Test Published in Nature Medicine

PharmaShots Interview: Janssen’s Alyssa Johnsen Shares Insights on the New Clinical data of Tremfya (guselkumab) Presented at ACR 2021 and Published in Arthritis & Rheumatology

PharmaShots Interview: Alto Neuroscience’s Dr. Amit Etkin Shares Insights on the Future of Psychiatric Medicines

PharmaShots Interview: Clario’s Joe Eazor Shares Insight on the Clinical Trial Innovation and Evidence

PharmaShots Interview: Synchrony’s Shannon Burke Shares Insight on Healthcare Consumerism

PharmaShots Interview: IMV’s Andrew Hall Shares Insight on DPX Technology for Bladder and Ovarian Cancer

Exclusive Interview with PharmaShots: Jeremiah Robison of Cionic Share Insight on the New Data of Neural Sleeve for Neurological & other Disorders

TOP 20 Animal Health Companies of 2020 by Total Revenue

PharmaShots Interview: Trialbee’s Matt Walz Shares Insight on Trialbee Honey Platform

Contact US

OUR INFORMATION

FOLLOW US